Page last updated: 2024-09-04

1,3,5-triaza-7-phosphaadamantane and Carcinoma, Anaplastic

1,3,5-triaza-7-phosphaadamantane has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti, P; Avezza, F; Bravin, A; Cavaletti, G; Ceresa, C; Gandin, V; Monfrini, M; Nicolini, G; Pellei, M; Santini, C; Semperboni, S1

Other Studies

1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and Carcinoma, Anaplastic

ArticleYear
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)
    Neurotoxicity research, 2018, Volume: 34, Issue:1

    Topics: Action Potentials; Adamantane; Animals; Antineoplastic Agents; Bortezomib; Carcinoma; Cell Line, Tumor; Cells, Cultured; Cisplatin; Copper; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Ganglia, Spinal; Gold; Humans; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Neurons; Organophosphorus Compounds; Peripheral Nerves; Polymerization; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tubulin

2018